VM

Vanitha Magesh

Active Director Director DIN 07565280
DIN 07565280 First appointment Jul 2016 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2016
Shareholding value •••• Premium profile

About Vanitha Magesh

Data last updated:

Vanitha Magesh is a Director at Asctel Pharmaceuticals Private Limited (since 2016). The company operates in Trading. Asctel Pharmaceuticals Private Limited reported revenue of ₹11.4 Lakh (FY 2024).

DIN 07565280
Primary Designation Director
Industry Trading
First Appointment 21 Jul 2016
Oldest Company Age 10 yrs
Largest company Asctel Pharmaceuticals Private Limited · ₹11.4 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jul 20162016₹11.4 Lakh (FY 2024)Active

Board colleagues of Vanitha Magesh

NameDINCompanyDesignation
Ramasamy Sivan07565463Asctel Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Asctel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vanitha Magesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vanitha Magesh

Vanitha Magesh currently holds 1 directorship: Asctel Pharmaceuticals Private Limited (Director, since 21 Jul 2016, revenue ₹11.4 Lakh (FY 2024)).

Vanitha Magesh was first appointed on 21 Jul 2016 as Director at Asctel Pharmaceuticals Private Limited.

The current boards of Vanitha Magesh's companies include Ramasamy Sivan (Asctel Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available